Journey Medical Corporation
DERMDrug Manufacturers - Specialty & Generic
$5.17−4.44%As of Oct 30vs prior close
- Market cap
- $145.9M
- P/E (TTM)
- –
- From 52W high
- −44.17%
- EPS (LTM)
- -$0.22
- Revenue (LTM)
- $68.2M
- Net margin
- -8.95%
- Dividend yield
- 0.00%
Nomior Score
38
Steady ProfileBottom 26% of the scored universe
Growth59
Quality38
Value57
Momentum33
Resilience32
Growth
+6.79%revenue a year over 5 fiscal years
YE20 $44.5MLTM $68.2M
Connections
Revenue to profitQ2 YE26
The net loss was 2% of revenue, narrower by 24 pts on a year.
Who owns it
1fund